Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array
- PMID: 12644634
- DOI: 10.1152/physiolgenomics.00157.2002
Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array
Abstract
A global picture of gene expression in the common immune-mediated skin disease, psoriasis, was obtained by interrogating the full set of Affymetrix GeneChips with psoriatic and control skin samples. We identified 1,338 genes with potential roles in psoriasis pathogenesis/maintenance and revealed many perturbed biological processes. A novel method for identifying transcription factor binding sites was also developed and applied to this dataset. Many of the identified sites are known to be involved in immune response and proliferation. An in-depth study of immune system genes revealed the presence of many regulating cytokines and chemokines within involved skin, and markers of dendritic cell (DC) activation in uninvolved skin. The combination of many CCR7+ T cells, DCs, and regulating chemokines in psoriatic lesions, together with the detection of DC activation markers in nonlesional skin, strongly suggests that the spatial organization of T cells and DCs could sustain chronic T-cell activation and persistence within focal skin regions.
Similar articles
-
Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.Br J Dermatol. 2007 Aug;157(2):249-58. doi: 10.1111/j.1365-2133.2007.07945.x. Epub 2007 May 8. Br J Dermatol. 2007. PMID: 17489975
-
Identification of differentially expressed genes in psoriasis using expression profiling approaches.Exp Dermatol. 2005 Sep;14(9):667-74. doi: 10.1111/j.0906-6705.2005.00338.x. Exp Dermatol. 2005. PMID: 16098126
-
T lymphocyte activation gene identification by coregulated expression on DNA microarrays.Genomics. 2004 Jun;83(6):989-99. doi: 10.1016/j.ygeno.2003.12.019. Genomics. 2004. PMID: 15177553
-
Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression.Trends Immunol. 2004 Jun;25(6):295-305. doi: 10.1016/j.it.2004.03.006. Trends Immunol. 2004. PMID: 15145319 Review. No abstract available.
-
Three decades of psoriasis research: where has it led us?Clin Dermatol. 2007 Nov-Dec;25(6):504-9. doi: 10.1016/j.clindermatol.2007.08.002. Clin Dermatol. 2007. PMID: 18021885 Review.
Cited by
-
Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory.Int J Mol Sci. 2024 May 31;25(11):6086. doi: 10.3390/ijms25116086. Int J Mol Sci. 2024. PMID: 38892277 Free PMC article.
-
Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology.J Invest Dermatol. 2023 Aug;143(8):1412-1422. doi: 10.1016/j.jid.2023.04.005. Epub 2023 Jun 20. J Invest Dermatol. 2023. PMID: 37341663 Free PMC article. Review.
-
Differentially Expressed Cell Cycle Genes and STAT1/3-Driven Multiple Cancer Entanglement in Psoriasis, Coupled with Other Comorbidities.Cells. 2022 Nov 30;11(23):3867. doi: 10.3390/cells11233867. Cells. 2022. PMID: 36497125 Free PMC article.
-
Transcriptional Basis of Psoriasis from Large Scale Gene Expression Studies: The Importance of Moving towards a Precision Medicine Approach.Int J Mol Sci. 2022 May 30;23(11):6130. doi: 10.3390/ijms23116130. Int J Mol Sci. 2022. PMID: 35682804 Free PMC article. Review.
-
Promising Strategies in Plant-Derived Treatments of Psoriasis-Update of In Vitro, In Vivo, and Clinical Trials Studies.Molecules. 2022 Jan 18;27(3):591. doi: 10.3390/molecules27030591. Molecules. 2022. PMID: 35163855 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical